NCT06406231

Magnetic Field Therapy Versus Transcutaneous Electrical Nerve-stimulation in Knee Osteoarthritis

Name: Clinical Trial NCT06406231
Creator: University Tunis El Manar
Keywords: Knee Osteoarthritis, comparing efficacy of TENS and PEMF in knee osteoarthritis, device, clinical trial, Tunisia

Magnetic Field Therapy Versus Transcutaneous Electrical Nerve-stimulation in Knee Osteoarthritis: a Head-to-head Trial

University Tunis El Manar·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Knee Osteoarthritis
Drug/Device/Intervention: comparing efficacy of TENS and PEMF in knee osteoarthritis
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: University Tunis El Manar
Location: Tunis, Tunisia

Timeline & enrollment

Phase: N/A
Start date: Sep 15, 2023
End date: Dec 01, 2024
Enrollment: 60 participants

Primary outcome

response to physical therapy

Summary

The effectiveness of PEMF in improving physical function among Osteoarthritic (OA) patients remains a topic of debate, leading to the American College of Rheumatology not yet endorsing its use in OA treatment. Therefore, it's essential to investigate PEMF therapy's efficacy in alleviating joint pain, stiffness, and enhancing physical function in knee OA patients Our study objectives were to evaluate the effectiveness and safety of PEMF therapy and to compare its efficacy with TENS in knee OA management.

ICD-10 classifications

Chronic instability of kneeGonarthrosis [arthrosis of knee]Other hypertrophic osteoarthropathyDislocation, sprain and strain of joints and ligaments of kneePatellofemoral disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06406231
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06406231 through Pure Global AI's free database. This phase not specified trial is sponsored by University Tunis El Manar and is currently Recruiting. The study focuses on Knee Osteoarthritis. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.